HIGHLIGHTS
- who: Report and collaborators from the General Internal Medicine, Kobe University Hospital, Kobe, JPN General Internal Medicine, Kobe University have published the research: Review began 05/23/2022 Review ended 06/09/2022 Published 06/13/2022 u00a9 Copyright, in the Journal: (JOURNAL) of June/13,/2022
- what: Even when the glucose-stimulated insulin secretion of u03b2 cells is impaired, good glycemic control can be obtained by using FRC therapy, especially that involving short-acting GLP-1 RA, as seen in our patient.
SUMMARY
Her family doctor had prescribed empagliflozin 10 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.